World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
39796
World Ranking
8533
National Ranking
839

David Y. Mason publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David Y. Mason sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 303 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David Y. Mason D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David Y. Mason sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David Y. Mason was affiliated with John Radcliffe Hospital in the United Kingdom. Their research spanned several interconnected areas within medicine and biochemistry, focusing particularly on cellular and molecular biology as well as rheumatology and infectious diseases.

Their scholarly output included publications in a variety of scientific venues, evidencing a multidisciplinary approach to medical research. The frequent publication venues for their work were:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Biochemical Journal
  • Metabolites
  • Toxicologic Pathology
  • Cancer Research

David Y. Mason contributed to multiple fields of study, with the main areas being Medicine and Biochemistry, Genetics and Molecular Biology. The subfields they explored included:

  • Cell Biology
  • Molecular Biology
  • Rheumatology
  • Emergency Medicine
  • Infectious Diseases

Their work touched on important research topics such as:

  • Microtubule and mitosis dynamics
  • Caveolin-1 and cellular processes
  • Protist diversity and phylogeny
  • Rheumatoid Arthritis Research and Therapies
  • Hematological disorders and diagnostics
  • Tuberculosis Research and Epidemiology
  • Immunotoxicology and immune responses

Among their most recent papers were:

  • Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics, 2020, Biochemical Journal
  • Artificial Intelligence in Toxicologic Pathology: Quantitative Evaluation of Compound-Induced Hepatocellular Hypertrophy in Rats, 2021, Toxicologic Pathology
  • Metabolic Profiling of Rheumatoid Arthritis Neutrophils Reveals Altered Energy Metabolism That Is Not Affected by JAK Inhibition, 2022, Metabolites
  • Metabolic profiling of rheumatoid arthritis neutrophils reveals altered energy metabolism that is not affected by JAK inhibition, 2022, bioRxiv (Cold Spring Harbor Laboratory)
  • Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signaling networks using SILAC-based phosphoproteomics, 2020, bioRxiv (Cold Spring Harbor Laboratory)

The scientist collaborated frequently with other researchers, including:

  • Dominic P. Byrne
  • Christopher J. Clarke
  • Philip Brownridge
  • Anton Kalyuzhnyy
  • Simon Perkins

Overall, David Y. Mason's research was situated at the intersection of medical science and molecular biology, combining advanced biochemical techniques with clinical applications, particularly in inflammatory and infectious conditions.

Best Publications

  • Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

    J. L. Cordell;B. Falini;W. N. Erber;A. K. Ghosh

  • The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

    H Stein;DY Mason;J Gerdes;N O'Connor

  • Transferrin receptor on endothelium of brain capillaries

    Wilfred A. Jefferies;Malcolm R. Brandon;Simon V. Hunt;Alan F. Williams

  • bcl-2 Protein in Non-Small-Cell Lung Carcinoma

    Francesco Pezzella;Helen Turley;Isinzu Kuzu;Mohammed Fahim Tungekar

  • Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

    S. A. Pileri;T. M. Grogan;N. L. Harris;P Banks

  • A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.

    Andrew J. McMichael;Jennifer R. Pilch;John W. Fabre;David Y. Mason

  • ALK-Positive Lymphoma: A Single Disease With a Broad Spectrum of Morphology

    Daniel Benharroch;Zarouhie Meguerian-Bedoyan;Laurence Lamant;Chauki Amin

  • Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population

    Harald Stein;Johannes Gerdes;Ulrich Schwab;Hilmar Lemke

  • Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes

    J. F Fawcett;C. L. L. Holness;L. A. Needham;H. Turley;H. Turley

  • Diagnosis of Human Lymphoma with Monoclonal Antileukocyte Antibodies

    Warnke Ra;Gatter Kc;Falini B;Hildreth P

  • The normal and malignant germinal centre.

    Harald Stein;Johannes Gerdes;David Y. Mason

  • Ultrastructural localization of bcl-2 protein.

    P. Monaghan;D. Robertson;T. A. S. Amos;M. J. S. Dyer

  • A New Subtype of Large B-Cell Lymphoma Expressing the ALK Kinase and Lacking the 2; 5 Translocation

    Georges Delsol;Laurence Lamant;Bernard Mariamé;Karen Pulford

  • FISH Analysis for the Detection of Lymphoma-Associated Chromosomal Abnormalities in Routine Paraffin-Embedded Tissue

    Roland A. Ventura;Jose I. Martin-Subero;Margaret Jones;Joanna McParland

  • Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis

    John Booss;Margaret M. Esiri;Wallace W. Tourtellotte;Wallace W. Tourtellotte;David Y. Mason

  • Retrovirus-Mediated Gene Transfer of NPM-ALK Causes Lymphoid Malignancy in Mice

    Martin U. Kuefer;A. Thomas Look;Karen Pulford;Frederick G. Behm

  • Immunohistological analysis of human lymphoma: correlation of histological and immunological categories.

    Harald Stein;Karl Lennert;Alfred C. Feller;David Y. Mason

  • Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

    W S Selby;G Janossy;D Y Mason;D P Jewell

  • A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily

    S. K. A. Law;K. J. Micklem;J. M. Shaw;Xi-Ping Zhang

  • The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p

    Alison H. Banham;Nigel Beasley;Elias Campo;Pedro L. Fernandez

Frequent Co-Authors

Karen Pulford
Karen Pulford University of Oxford
Kevin C. Gatter
Kevin C. Gatter University of Oxford
Georges Delsol
Georges Delsol Federal University of Toulouse Midi-Pyrénées
Stefano Pileri
Stefano Pileri European Institute of Oncology
Brunangelo Falini
Brunangelo Falini University of Perugia
Elias Campo
Elias Campo University of Barcelona
Yasodha Natkunam
Yasodha Natkunam Stanford University
Stephan W. Morris
Stephan W. Morris St. Jude Children's Research Hospital
Harald Stein
Harald Stein Charité - University Medicine Berlin
Alison H. Banham
Alison H. Banham University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond the traditional Doctor of Medicine (MD) track, many students seek related online degrees that can open unique and rewarding roles in healthcare. One rapidly growing pathway is psychiatric mental health nursing. For those wanting to fast-track their education, there are now options like the fastest pmhnp program that allow licensed nurses to quickly become advanced practice psychiatric-mental health nurse practitioners.

Healthcare administration is another high-demand field with flexible degree options accessible online. If you’re considering leadership or management in hospitals or clinics, a health care administration online degree can provide the essential skills without the need for on-campus attendance. Cost is often a key concern for graduate education—multiple programs offer a masters in healthcare administration cost structure that’s budget-friendly while still delivering a robust curriculum.

For nurses aiming for the highest clinical roles, there are also most affordable online dnp programs focused on clinical leadership and advanced patient care. Exploring these related online degrees allows students to find the career path that best matches their interests and goals while offering flexible, affordable learning opportunities in the healthcare sector.

Best Scientists Citing David Y. Mason

Recently Published Articles